Insider Trading History of Garner William J

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Garner William J since 2009. The trader's CIK number is 1407235. At the time of the last reporting, Garner William J was the Chief Executive Offi of Delmar Pharmaceuticals, Inc.. (stock ticker symbol DMPI). Also see all insider trading activities at Delmar Pharmaceuticals, Inc..

Note that in the past Garner William J also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Delmar Pharmaceuticals, Inc. (DMPI) by Garner William J

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2015 DMPI 16,666 $9,999 0 $0 0 $0
2014 DMPI 0 $0 80,000 $104,000 0 $0
2013 DMPI 5,000 $5,000 0 $0 0 $0

Yearly summary of insider trading at Valentis Inc (UGRP.OB) by Garner William J

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2009 UGRP.OB 110,800 $10,008 0 $0 0 $0


Insider trading activities at 2 companies by Garner William J:

1. Delmar Pharmaceuticals, Inc. (DMPI)

2. Valentis Inc (UGRP.OB)

Table 1. Insider trading of Delmar Pharmaceuticals, Inc. (DMPI) by Garner William J

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2015-07-16 DMPI Buy 16,666 .60 9,999
2014-03-18 DMPI Sale 80,000 1.30 104,000
2013-09-20 DMPI Buy 5,000 1.00 5,000

Table 2. Insider trading of Valentis Inc (UGRP.OB) by Garner William J

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2009-03-13 UGRP.OB Buy 1,000 .09 90
2009-03-13 UGRP.OB Buy 1,000 .09 90
2009-03-11 UGRP.OB Buy 1,000 .09 90
2009-03-05 UGRP.OB Buy 5,000 .08 400
2009-02-25 UGRP.OB Buy 1,000 .10 100
2009-01-29 UGRP.OB Buy 16,000 .15 2,400
2009-01-30 UGRP.OB Buy 17,800 .14 2,403
2009-01-26 UGRP.OB Buy 5,000 .17 850
2009-01-27 UGRP.OB Buy 10,000 .12 1,200
2009-01-21 UGRP.OB Buy 48,000 .04 2,160
2009-01-20 UGRP.OB Buy 5,000 .04 225

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Garner William J (Chief Executive Offi of Delmar Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.